Cytokine genetic polymorphisms and prostate cancer aggressiveness
- PMID: 19474090
- PMCID: PMC2718072
- DOI: 10.1093/carcin/bgp124
Cytokine genetic polymorphisms and prostate cancer aggressiveness
Abstract
Prostate cancer (PCa) is one of the most common cancers in the world. Inflammation has been described as a risk factor for PCa and depends on the production of cytokines in response to tissue damage or the presence of stimuli that induces cellular stress. Interindividual variation in cytokine production is partially controlled by single-nucleotide polymorphisms (SNPs) that have been associated with differential production of cytokines. We have recently showed that SNP-SNP interactions of cytokine genes are associated with PCa risk. However, little is known about the association of cytokine SNPs and PCa aggressiveness. In this study, we evaluated the association of 15 SNPs in five cytokine genes and aggressiveness of PCa in African- and Caucasian-American individuals. Caucasian Americans with the genotypes IL10-1082GG or IL1B+3954TT had 2.31-fold [95% confidence interval (CI) = 1.13-4.72] and 3.11 (95% CI = 1.20-8.06)-fold risk, respectively, of developing aggressive PCa, as compared with individuals without those genotypes. We did not find any associations in the African-American group. Using Multivariate Adaptive Regression Splines modeling for exploratory SNP-SNP interactions, our results showed that more aggressive PCa in Caucasians Americans is associated with the CT genotype at IL8-47 [odds ratios (OR) = 3.50; 95% CI = 1.13-10.88] or combined genotypes of IL1B-511CC and IL10-1082GG (OR = 3.38; 95% CI = 1.70-6.71). Unfortunately, the same analysis could not be performed in the African-Americans due to limited number of individuals. With limited sample size, the results from this study suggest that SNPs in cytokine genes may be associated with PCa aggressiveness. More extensive studies are warranted to validate our findings.
Figures

Similar articles
-
Interactions of cytokine gene polymorphisms in prostate cancer risk.Carcinogenesis. 2008 Mar;29(3):573-8. doi: 10.1093/carcin/bgm277. Epub 2008 Jan 3. Carcinogenesis. 2008. PMID: 18174250
-
Genetic polymorphism and prostate cancer aggressiveness: a case-only study of 1,536 GWAS and candidate SNPs in African-Americans and European-Americans.Prostate. 2013 Jan;73(1):11-22. doi: 10.1002/pros.22532. Epub 2012 May 1. Prostate. 2013. PMID: 22549899 Free PMC article.
-
Ethnic differences in cytokine gene polymorphisms: potential implications for cancer development.Cancer Immunol Immunother. 2008 Jan;57(1):107-14. doi: 10.1007/s00262-007-0358-4. Epub 2007 Jul 6. Cancer Immunol Immunother. 2008. PMID: 17618436 Free PMC article.
-
Pro-inflammatory cytokines and chemokines initiate multiple prostate cancer biologic pathways of cellular proliferation, heterogeneity and metastasis in a racially diverse population and underlie the genetic/biologic mechanism of racial disparity: Update.Urol Oncol. 2021 Jan;39(1):34-40. doi: 10.1016/j.urolonc.2020.08.019. Epub 2020 Sep 6. Urol Oncol. 2021. PMID: 32900629 Review.
-
Racial disparities: disruptive genes in prostate carcinogenesis.Front Biosci (Schol Ed). 2017 Jun 1;9(2):244-253. doi: 10.2741/S485. Front Biosci (Schol Ed). 2017. PMID: 28410117 Review.
Cited by
-
Prostate cancer and inflammation: the evidence.Histopathology. 2012 Jan;60(1):199-215. doi: 10.1111/j.1365-2559.2011.04033.x. Histopathology. 2012. PMID: 22212087 Free PMC article. Review.
-
Inflammation induced by lipopolysaccharide advanced androgen receptor expression and epithelial-mesenchymal transition progress in prostatitis and prostate cancer.Transl Androl Urol. 2021 Nov;10(11):4275-4287. doi: 10.21037/tau-21-964. Transl Androl Urol. 2021. PMID: 34984192 Free PMC article.
-
The impact of genetic variants in inflammatory-related genes on prostate cancer risk among men of African Descent: a case control study.Hered Cancer Clin Pract. 2013 Dec 23;11(1):19. doi: 10.1186/1897-4287-11-19. Hered Cancer Clin Pract. 2013. PMID: 24359571 Free PMC article.
-
The impact of common genetic variations in genes of the sex hormone metabolic pathways on steroid hormone levels and prostate cancer aggressiveness.Cancer Prev Res (Phila). 2011 Dec;4(12):2044-50. doi: 10.1158/1940-6207.CAPR-11-0283. Epub 2011 Sep 7. Cancer Prev Res (Phila). 2011. PMID: 21900597 Free PMC article.
-
Inflammatory genetic markers of prostate cancer risk.Cancers (Basel). 2010 Jun 8;2(2):1198-220. doi: 10.3390/cancers2021198. Cancers (Basel). 2010. PMID: 24281113 Free PMC article.
References
-
- Parkin DM, et al. Global cancer statistics, 2002. CA Cancer J. Clin. 2005;55:74–108. - PubMed
-
- American Cancer Society. Cancer Facts and Figures. 2007. www.cancer.org. (Nov 2008, date last accessed)
-
- Schaid DJ. The complex genetic epidemiology of prostate cancer. Hum. Mol. Genet. 2004 13 Spec No. 1, R103–R121. - PubMed
-
- Jemal A, et al. Cancer statistics, 2007. CA Cancer J. Clin. 2007;57:43–66. - PubMed
-
- National Cancer Institute. Surveillance, Epidemiology and End Results. 2007. http://seer.cancer.gov/. (Nov 2008, date last accessed)
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical